{"data":{"billId":"116-hr-3443","congress":116,"type":"HR","number":"3443","title":"To clarify the regulatory framework with respect to certain nonprescription drugs that are marketed without an approved drug application, and for other purposes.","shortTitle":null,"originChamber":"House","introducedDate":"2019-06-24","updateDate":"2026-01-20T15:33:02Z","latestAction":{"actionDate":"2019-07-24","text":"Sponsor introductory remarks on measure. (CR E971)"},"policyArea":"Health","sponsors":[{"bioguideId":"D000197","district":1,"firstName":"DIANA","fullName":"Rep. DeGette, Diana [D-CO-1]","isByRequest":"N","lastName":"DEGETTE","party":"D","state":"CO","url":"https://api.congress.gov/v3/member/D000197?format=json"}],"cosponsorsCount":3,"committeesCount":1,"actionsCount":5,"textVersionsCount":1,"url":"https://civdotiq.org/bill/116-hr-3443"},"meta":{"apiVersion":"v1","timestamp":"2026-10-03T01:53:11.524Z","source":"congress.gov","license":"MIT","documentation":"https://civdotiq.org/docs/api"}}